Search
Robenidine
go.drugbank.com/drugs/DB11542ExperimentalVet approvedFarmers alternate the use of robenidine with other antimicrobial agents in order to maintain effectiveness by slowing the development of antimicrobial resistance. … Despite the availability of other agents to treat coccidiosis, robenidine has been proven to be effective in delaying the development of antibiotic resistance through intermittent and rotating use with
Tylosin
go.drugbank.com/drugs/DB11475ExperimentalVet approvedIt has a broad spectrum of activity against Gram-positive organisms and a limited range of Gram-negative organisms. Tylosin is produced as a fermentation product of Streptomyces fradiae.
Mixtures: Tylan 40 Sulfa-G PremixPAC-113
go.drugbank.com/drugs/DB05756InvestigationalPAC-113 an anti-fungal, for the treatment of oral candidiasis infections. It is a 12 amino-acid antimicrobial peptide derived from a naturally occurring histatin protein found in saliva.
EHT899
go.drugbank.com/drugs/DB05108ExperimentalEHT899 is a proprietary formulation of an HBV viral protein designed to eliminate the undesirable immune response elicited by the HBV infection.
PEV3A
go.drugbank.com/drugs/DB05144InvestigationalThe two synthetic peptide vaccine components mimic the native structure of important antigens of the malaria parasite. … PEV3A is a prophylactic malaria vaccine that acts against various stages of the disease. It is a two-component vaccine that contains the virosome formulated peptide mimetics PEV301 and PEV302.
Monlunabant
go.drugbank.com/drugs/DB21537InvestigationalMonlunabant has a monoisotopic molecular weight of 590.11 Da. … The usage of the INN stem '-nabant' in the name indicates that Monlunabant is a cannabinoid receptor antagonist.
Recombinant Human Thrombopoietin
go.drugbank.com/drugs/DB16364Investigational[A225691, A225696] This drug is used in the treatment of thrombocytopenia. … Recombinant human thrombopoietin is a full-length glycosylated cytokine produced by Chinese hamster ovary cells and is used to promote the generation of megakaryocytes and platelets.
VLTS-934
go.drugbank.com/drugs/DB05597InvestigationalVLTS-934 was developed by Valentis inc. for the treatment of Peripheral Arterial Disease (PAD). … It was under investigation in clinical trial NCT00113009 (Trial of VLTS-934 in Subjects With Intermittent Claudication Secondary to Peripheral Arterial Disease).
Itrocainide
go.drugbank.com/drugs/DB20210ExperimentalItrocainide has a monoisotopic molecular weight of 361.22 Da. … The usage of the INN stem '-cain-' in the name indicates that Itrocainide is a class I antiarrhythmic, procainamide and lidocaine derivative.
Asoprisnil ecamate
go.drugbank.com/drugs/DB20225ExperimentalThe usage of the INN stem '-nil' in the name indicates that Asoprisnil ecamate is a benzodiazepine receptor antagonist/agonist. Asoprisnil ecamate has a monoisotopic molecular weight of 520.29 Da.